New York State Teachers Retirement System Has $74.26 Million Holdings in CME Group Inc. $CME

11 Jan 2026, 09:44 by Scott Moore · The Cerbat Gem

New York State Teachers Retirement System decreased its stake in CME Group Inc. (NASDAQ:CME – Free Report) by 0.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 274,829 shares of the financial services provider’s stock after selling 2,051 shares during the quarter. New York State Teachers Retirement System owned 0.08% of CME Group worth $74,256,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CME. Vanguard Group Inc. raised its position in shares of CME Group by 1.5% in the 2nd quarter. Vanguard Group Inc. now owns 35,176,376 shares of the financial services provider’s stock valued at $9,695,313,000 after acquiring an additional 532,549 shares during the period. Geode Capital Management LLC raised its holdings in CME Group by 3.6% in the second quarter. Geode Capital Management LLC now owns 9,178,681 shares of the financial services provider’s stock worth $2,524,271,000 after purchasing an additional 319,899 shares during the period. Norges Bank bought a new position in shares of CME Group during the second quarter worth $1,571,447,000. Ameriprise Financial Inc. grew its holdings in shares of CME Group by 2.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 4,682,066 shares of the financial services provider’s stock valued at $1,289,910,000 after buying an additional 92,925 shares during the period. Finally, Arrowstreet Capital Limited Partnership increased its position in shares of CME Group by 6.6% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,833,090 shares of the financial services provider’s stock valued at $1,056,476,000 after buying an additional 238,522 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on CME shares. Weiss Ratings reiterated a “buy (b+)” rating on shares of CME Group in a report on Monday, December 29th. Raymond James Financial raised their price target on CME Group from $307.00 to $311.00 and gave the stock an “outperform” rating in a research report on Monday, January 5th. UBS Group reiterated a “neutral” rating on shares of CME Group in a research report on Tuesday. Piper Sandler raised their target price on shares of CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a report on Thursday, November 13th. Finally, The Goldman Sachs Group cut their price target on shares of CME Group from $264.00 to $263.00 and set a “sell” rating on the stock in a research note on Thursday, December 4th. Eight research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have given a Sell rating to the company. According to MarketBeat, CME Group presently has an average rating of “Hold” and an average price target of $291.06.

Get Our Latest Analysis on CME Group

Insider Activity at CME Group

In other news, CEO Terrence A. Duffy sold 25,000 shares of the stock in a transaction that occurred on Thursday, December 11th. The stock was sold at an average price of $269.55, for a total value of $6,738,750.00. Following the completion of the sale, the chief executive officer owned 65,804 shares of the company’s stock, valued at approximately $17,737,468.20. This represents a 27.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director William R. Shepard bought 251 shares of the stock in a transaction that occurred on Tuesday, December 30th. The shares were purchased at an average price of $278.37 per share, for a total transaction of $69,870.87. Following the completion of the acquisition, the director owned 258,710 shares of the company’s stock, valued at $72,017,102.70. The trade was a 0.10% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 0.30% of the company’s stock.

CME Group Stock Performance

Shares of CME opened at $262.45 on Friday. The stock has a market capitalization of $94.64 billion, a price-to-earnings ratio of 25.43, a PEG ratio of 3.39 and a beta of 0.27. CME Group Inc. has a 12 month low of $225.46 and a 12 month high of $290.79. The firm has a fifty day simple moving average of $273.95 and a 200 day simple moving average of $271.89. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME – Get Free Report) last issued its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.63 by $0.05. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The firm had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period in the previous year, the business earned $2.68 EPS. The company’s revenue was down 3.0% compared to the same quarter last year. Research analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 30th. Investors of record on Friday, December 12th were issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date was Friday, December 12th. CME Group’s dividend payout ratio is presently 48.45%.

CME Group Company Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.